Treatments & Clinical Trials

Stay informed about the latest breakthroughs in stem cell therapies and clinical trials that hold promise for a wide range of medical conditions. Explore how groundbreaking treatments and ongoing research are paving the way for the future of healthcare.

Cord Blood Expansion: Why Your Baby's Stem Cells Can Now Treat Adults

Lab-expanded cord blood stem cells now enable adult transplants, shorten recovery, and make newborn banking a lasting medical resource.

The Evolution of Stem Cells: From Cord Blood to iPSC Technology

Overview of cord blood, cord tissue, placental cells, exosomes and iPSC advances, and why banking newborn cells may enable future regenerative therapies.

Are iPSCs the Key to Treating Parkinson’s and Autoimmune Diseases?

iPSCs can replace dopamine neurons in Parkinson’s and generate regulatory immune cells for autoimmune diseases; trials show promise despite cost, survival, and safety challenges.

iPSC Clinical Trials: The Latest Breakthroughs in Stem Cell Research

Overview of global iPSC clinical trials — Parkinson’s, eye, spinal and fertility therapies; safety, manufacturing challenges, and cord-blood/tissue banking.

Beyond Cord Blood: Understanding Induced Pluripotent Stem Cells (iPSCs)

How iPSCs differ from cord blood, their medical uses and risks, and why banking cord blood now keeps options open for future iPSC therapies.

How iPSC Therapies Are Changing the Landscape of Cell Treatment

iPSC therapies reprogram adult cells into personalized regenerative treatments, improve drug testing, and show why newborn stem cell banking matters.

What Are iPSCs? The Future of Regenerative Medicine Explained

What are iPSCs and how they work: reprogrammed adult cells enabling personalized, embryo-free therapies, disease models, and future tissue repair.

Top Uses of Stem Cells in Family Medicine

How stem cell therapies are used in family medicine for tissue repair, wound healing, pain control, neurological and autoimmune care, and cord-blood banking.